Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

Goodyear CS., Patel A., Barnes E., Willicombe M., Siebert S., de Silva TI., Snowden JA., Lim SH., Bowden SJ., Billingham L., Richter A., Carroll M., Carr EJ., Beale R., Rea D., Parry H., Pirrie S., Lim Z., Satsangi J., Dunachie SJ., Cook G., Miller P., Basu N., Gilmour A., Hodgkins A-M., Evans L., Hughes A., Longet S., Meacham G., Yong KL., A'Hearne MJ., Koh MBC., Burns SO., Orchard K., Paterson C., McIlroy G., Murray SM., Thomson T., Dimitriadis S., Goulston L., Miller S., Keillor V., Prendecki M., Thomas D., Kirkham A., McInnes IB., Kearns P., Beesley R., Churchill V., Insch E., Loughton H., MacDonald E., Lax S., Lowe F., Magwaro S., Gradwell M., Kinsella F., Rolfe H., McIntyre S., Mortimer P., Al-Taei S., Tadros S., Workman S., Arnott M., Brock J., Melville A., Najm A., Rutherford M., Sunzini F., Herman LS., Hobbs A., Ragno M., Wu MY., Selby R., Clay J., Hutchison C., Lown R., Lwin MN., Meardon N., Kelleher P., Lightstone L., Walters T., Denyer J., Ibrahim R., Gleeson S., Martin P., McAdoo S., Baker H., Horswill S., Parungao N., Saich S., Cullinane J., Irwin S., Klenerman P., Marjot T., Chakraverty R., Holroyd C., Kavi J., Trown D., Babbage G., Chackathayil J., Faria P., Ingham K., Miah M., Miranda M., O'Reilly N., Smith C., Driver K., Gauntlett K., Farthing A., Rundell S., Smith E., Tong A., Woolcock K., Hanke D., Laidlaw S., Malik Z., Nguyen D., Provine N., Tipton T., Walker V.

DOI

10.1016/s2665-9913(24)00065-1

Type

Journal article

Publisher

Elsevier BV

Publication Date

2024-06-01T00:00:00+00:00

Volume

6

Pages

e339 - e351

Permalink More information Close